Fieldfisher advised Synairgen Plc on the deal.AIM-quoted drug discovery and development company Synairgen plc completed its recent £18 million fundraising. The fundraising consisted of a subscription…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
